Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGRX Mangoceuticals, Inc.

Trading 03-31 10:28:13 EDT

2.15

-0.23

-9.66%

High2.34	Low2.11	Vol24.94K
Open2.27	D1 Closing2.38	Amplitude9.39%
Mkt Cap11.11M	Tradable Cap7.83M	Total Shares5.17M
T/O55.28K	T/O Rate0.69%	Tradable Shares3.64M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"MGRX","market":"US","secType":"STK","nameCN":"Mangoceuticals, Inc.","latestPrice":2.15,"timestamp":1743431145344,"preClose":2.38,"halted":0,"volume":24941,"delay":0,"floatShares":3640500,"shares":5168796,"eps":-5.645803,"marketStatus":"Trading","change":-0.23,"latestTime":"03-31 10:28:13 EDT","open":2.27,"high":2.335,"low":2.1115,"amount":55282.893738800005,"amplitude":0.093908,"askPrice":2.19,"askSize":100,"bidPrice":2.12,"bidSize":119,"shortable":0,"etf":0,"ttmEps":-5.645803,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"listingDate":1679371200000,"exchange":"NASDAQ","adjPreClose":2.38,"preHourTrading":{"tag":"盘前","latestPrice":2.3301,"preClose":2.38,"latestTime":"09:15 EDT","volume":2542,"amount":5924.4845921999995,"timestamp":1743426927939},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.38,"latestTime":"19:36 EDT","volume":11209,"amount":25310.85,"timestamp":1743205000733},"volumeRatio":0.20326},"requestUrl":"/m/hq/s/MGRX/tweets","defaultTab":"tweets","newsList":[{"id":"2522807914","title":"Mangoceuticals Inc - Secures Exclusive Rights for Diabetinol in U.S. and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2522807914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522807914?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 21:10","pubTimestamp":1742908248,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q81EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2522079322","title":"Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2522079322","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522079322?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 21:00","pubTimestamp":1742907600,"startTime":"0","endTime":"0","summary":"Diabetinol is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace. Diabetinol is a plant-based nutraceutical clinically supported and patented extract of citrus peel rich in polymethoxylated flavones , including nobiletin and tangeretin. Based on clinical studies performed, these compounds have demonstrated significant metabolic effects, particularly in how the body processes and utilizes sugar and fat. Mechanistically, Diabetinol works by improving insulin sensitivity, enhancing GLUT4-mediated glucose uptake in tissues, suppressing hepatic glucose production, and activating key enzymes involved in lipid metabolism. It also reduces systemic inflammation and oxidative stress—two of the primary biological drivers of insulin resistance and metabolic dysfunction.The healthcare burden associated with this is immense. U.S. diabetes-related healthcare costs are already over $400 billion per year. Meanwhile, global spendi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mangoceuticals-expands-33-billion-addressable-130000419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2346227817.USD","BK4208","LU0170899867.USD","ED","BK4585","BK4128","BK4588","MGRX"],"gpt_icon":0},{"id":"2520354271","title":"Mangoceuticals, Inc. Approves Key Amendments at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2520354271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520354271?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:29","pubTimestamp":1742390958,"startTime":"0","endTime":"0","summary":"Mangoceuticals, Inc. ( ($MGRX) ) has provided an announcement. On March 17, 2025, Mangoceuticals, Inc. held a Special Meeting where shareholders ap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mangoceuticals-inc-approves-key-amendments-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mangoceuticals-inc-approves-key-amendments-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2512449557","title":"BRIEF-Mangoceuticals Announces The Launch Of “Peachesrx”","url":"https://stock-news.laohu8.com/highlight/detail?id=2512449557","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512449557?lang=en_us&edition=full_marsco","pubTime":"2025-02-20 20:14","pubTimestamp":1740053688,"startTime":"0","endTime":"0","summary":"BRIEF-Mangoceuticals Announces The Launch Of “Peachesrx”Feb 20 (Reuters) - Mangoceuticals Inc MGRX.O:MANGOCEUTICALS ANNOUNCES THE LAUNCH OF “PEACHESRX” - A WOMEN'S TELEHEALTH BRAND FOCUSED ON PERSONAL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250220:nTUA1JJXQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2512144684","title":"Mangoceuticals Announces the Launch of “Peachesrx” - a Women's Telehealth Brand Focused on Personalized Wellness and Glp-1 Weight Loss Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2512144684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512144684?lang=en_us&edition=full_marsco","pubTime":"2025-02-20 20:00","pubTimestamp":1740052800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250220:nTUA1JJXQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2510371352","title":"BRIEF-Mangoceuticals Advances Research On Avian Flu Solution For Poultry","url":"https://stock-news.laohu8.com/highlight/detail?id=2510371352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510371352?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 21:19","pubTimestamp":1739366350,"startTime":"0","endTime":"0","summary":"BRIEF-Mangoceuticals Advances Research On Avian Flu Solution For PoultryFeb 12 (Reuters) - Mangoceuticals MGRX.O:MANGOCEUTICALS INC - ADVANCES RESEARCH ON AVIAN FLU SOLUTION FOR POULTRYMANGOCEUTICALS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P30WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2510796433","title":"Mangoceuticals Inc - Advances Research on Avian Flu Solution for Poultry","url":"https://stock-news.laohu8.com/highlight/detail?id=2510796433","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510796433?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 21:05","pubTimestamp":1739365539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P30WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2510379610","title":"Mangoceuticals Inc - Engages Vipragen Biosciences for Antiviral Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2510379610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510379610?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 21:05","pubTimestamp":1739365539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P30WP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2509222434","title":"Mangoceuticals Inc - Initial H1n1 Trial Shows Significant Reduction in Viral Load","url":"https://stock-news.laohu8.com/highlight/detail?id=2509222434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509222434?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 20:00","pubTimestamp":1738843202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA48V1ZN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2509222316","title":"Mangoceuticals Advances H1n1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5n1 Cohort for Expanded Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2509222316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509222316?lang=en_us&edition=full_marsco","pubTime":"2025-02-06 20:00","pubTimestamp":1738843202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA48V1ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2508414310","title":"Mangoceuticals executes exclusive distribution agreement with Propre","url":"https://stock-news.laohu8.com/highlight/detail?id=2508414310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508414310?lang=en_us&edition=full_marsco","pubTime":"2025-02-03 21:46","pubTimestamp":1738590384,"startTime":"0","endTime":"0","summary":"Mangoceuticals (MGRX) announces that it has entered into an exclusive Master Distribution Agreement with Propre Energie, Inc., the developer of ski...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mangoceuticals-executes-exclusive-distribution-agreement-with-propre?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mangoceuticals-executes-exclusive-distribution-agreement-with-propre?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2508766148","title":"Mangoceuticals, Inc. Executes Exclusive Distribution Agreement With Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2508766148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508766148?lang=en_us&edition=full_marsco","pubTime":"2025-02-03 21:30","pubTimestamp":1738589401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250203:nTUA4JSMY8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2505738873","title":"Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2505738873","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505738873?lang=en_us&edition=full_marsco","pubTime":"2025-01-22 05:59","pubTimestamp":1737496785,"startTime":"0","endTime":"0","summary":"Mangoceuticals, Inc. ( ($MGRX) ) has shared an announcement. Mangoceuticals, Inc. entered into a Debt Conversion Agreement with Mill End Capital Lt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mangoceuticals-inc-finalizes-debt-conversion-and-appointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mangoceuticals-inc-finalizes-debt-conversion-and-appointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2495660615","title":"BUZZ-Hims & Hers shines bright in a testing year for telehealth stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2495660615","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495660615?lang=en_us&edition=full_marsco","pubTime":"2024-12-31 22:41","pubTimestamp":1735656118,"startTime":"0","endTime":"0","summary":"** Shares of Hims & Hers Health    more than double, while other telehealth firms are set to end the year in declines   ** HIMS' shares set for their second straight year of gains helped by co's offering of compounded versions of GLP-1 weight-loss drugs such as Novo Nordisk's    Wegovy    ** HIMS, Mangoceuticals   , WeightWatchers    and Teladoc Health    offer compounded and branded versions of GLP-1 weight-loss drugs on their platforms    ** Soaring demand for weight-loss drugs made by Eli Lilly  and Novo Nordisk have pushed patients to cheaper compounded versions    ** Shares of telehealth firms have been volatile this year on \"headlines tied to the overall supply availability of all things GLP-1-related,\" brokerage Leerink Partners says    ** Shares of TDOC and LFMD were also hit after Amazon  announced low-cost telehealth services for Prime members; shares of LFMD fell to nearly four-month low    ** Shares of HIMS have more than doubled YTD    ** Shares of TDOC set for fourth stra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","HIMS","LU2237443978.SGD","LU1935043023.USD","LU1989764748.USD","LU1366192091.USD","AMZN","LU0203202063.USD","LU0823434740.USD","LU0719512351.SGD","IE00BZ1G4Q59.USD","MGRX","LU0072462426.USD","LU1861558580.USD","LU0006306889.USD","LU2237438978.USD","LU0289739699.SGD","LU1815333072.USD","BK4567","LU2242650005.HKD","LLY","BK4532","LU2247934214.USD","LU1244550221.USD","IE0002141913.USD","LU1316542783.SGD","LU0316494557.USD","LU0456855351.SGD","IE000KEQY171.SGD","LU2023251221.USD","IE00B775H168.HKD","BK4535","USAW.SI","LU0308772762.SGD","LU2456880835.USD","TDOC","LU0689472784.USD","LU2106854487.HKD","LU1778281490.HKD","WW","LU1629891620.HKD","LU0238689110.USD","LU0889565833.HKD","LU1720051108.HKD","LU0128525929.USD","LU0267386448.USD","LU1235294995.USD","LU1868836757.USD","LU2756315664.SGD","LFMD"],"gpt_icon":1},{"id":"2492886436","title":"Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2492886436","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492886436?lang=en_us&edition=full_marsco","pubTime":"2024-12-20 07:31","pubTimestamp":1734651060,"startTime":"0","endTime":"0","summary":"Shares of Mangoceuticals were trading higher in the after-hours market following news the company acquired a patent for mushroom-derived compositions and methods of treatment.After the bell, the company's shares were trading 22% higher at $3.06. The stock lost under 1% in Thursday's regular session, closing at $2.44.Mangoceuticals, which develops men's health and wellness products, said it plans to leverage this patent to research and develop a new line of wellness products.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["Z4D.SI","BK4128","MGRX"],"gpt_icon":0},{"id":"2492562438","title":"Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2492562438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492562438?lang=en_us&edition=full_marsco","pubTime":"2024-12-20 06:33","pubTimestamp":1734647580,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUABLGJXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2488679461","title":"Mangoceuticals initiates investigation into potential stock manipulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2488679461","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488679461?lang=en_us&edition=full_marsco","pubTime":"2024-12-04 20:10","pubTimestamp":1733314241,"startTime":"0","endTime":"0","summary":"Mangoceuticals (MGRX) has launched an investigation into potential stock manipulation related to and following its recent reverse stock split, whic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mangoceuticals-initiates-investigation-into-potential-stock-manipulation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mangoceuticals-initiates-investigation-into-potential-stock-manipulation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2488913162","title":"Mangoceuticals, Inc. Initiates Investigation Into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2488913162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488913162?lang=en_us&edition=full_marsco","pubTime":"2024-12-04 20:05","pubTimestamp":1733313946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N516E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2479088072","title":"Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479088072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479088072?lang=en_us&edition=full_marsco","pubTime":"2024-10-31 20:00","pubTimestamp":1730376002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUA3H8S8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2477233230","title":"Mangoceuticals Shares Fall 3.3% on Plan to Evaluate Potential Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2477233230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477233230?lang=en_us&edition=full_marsco","pubTime":"2024-10-22 21:31","pubTimestamp":1729603875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nFWN3LY0VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mangorx.com","stockEarnings":[{"period":"1week","weight":-0.4664},{"period":"1month","weight":-0.4628},{"period":"3month","weight":-0.0846},{"period":"6month","weight":-0.3386},{"period":"1year","weight":-0.2685},{"period":"ytd","weight":-0.0165}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.","exchange":"NASDAQ","name":"Mangoceuticals, Inc.","nameEN":"Mangoceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mangoceuticals, Inc.,MGRX,Mangoceuticals, Inc.股票,Mangoceuticals, Inc.股票老虎,Mangoceuticals, Inc.股票老虎国际,Mangoceuticals, Inc.行情,Mangoceuticals, Inc.股票行情,Mangoceuticals, Inc.股价,Mangoceuticals, Inc.股市,Mangoceuticals, Inc.股票价格,Mangoceuticals, Inc.股票交易,Mangoceuticals, Inc.股票购买,Mangoceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}